Adult Psychiatry· 16 min read

Low Testosterone and Depression: Why These Conditions Keep Getting Misdiagnosed

Low testosterone and depression share nearly identical symptom profiles. Fatigue, low motivation, irritability, poor concentration, disrupted sleep, decreased libido. Both conditions produce these symptoms, and the overlap is close enough that one is routinely mistaken for the other.

The result is men cycling through antidepressants that don’t address the hormonal component, or men receiving testosterone replacement without anyone evaluating whether a mood disorder is also present. Neither approach captures the full picture. Understanding where these conditions overlap, where they diverge, and what the research actually supports is essential for getting the right treatment.

When the workup points at the hormone, TRT by telehealth is how I manage it across North Carolina.

Many of these men are already taking an antidepressant when they start testosterone. Running both safely is its own topic, covered in my guide to combining the two.

When the antidepressant itself is the question, I cover how to think through that decision in my guide to what to do when your antidepressant isn’t working.

When mood is the primary problem, start with my overview of depression treatment in North Carolina.

If you are weighing treatment, see my guide to testosterone therapy for North Carolina men.

Hormones are one part of a broader metabolic picture in mood, which I discuss in metabolic psychiatry.

Men still building their families should also weigh fertility before starting treatment. I cover that in my guide to TRT, fertility, and testicular atrophy.


The Symptom Overlap Problem

Low testosterone (hypogonadism) and major depressive disorder share a remarkably similar symptom profile. Both conditions can produce persistent fatigue, low motivation, difficulty concentrating, irritability, disrupted sleep, decreased libido, and a general sense that something is “off” without a clear explanation.

The overlap isn’t a coincidence. Testosterone is a neuroactive steroid that directly influences the brain’s mood-regulating systems. It modulates serotonin signaling, affects dopamine release, and interacts with GABA receptors in ways that directly impact emotional regulation (1). When testosterone levels drop below the functional range, the neurochemical effects can mimic what clinicians see in clinical depression.

Here’s where it gets complicated: depression itself can suppress testosterone production. The hypothalamic-pituitary-gonadal (HPG) axis, which controls testosterone secretion, is sensitive to the same stress hormones (particularly cortisol) that are elevated in depressive states. Studies have documented significantly lower testosterone concentrations in men with depression compared to healthy controls (2).

So the relationship runs in both directions: low testosterone can cause depressive symptoms, and depression can lower testosterone. Evaluating only one side of this equation means the other side gets missed. The relationship between mood and hormones is further complicated by the fact that the chemical imbalance model of depression has been increasingly questioned by research.

Low testosterone and depression symptom overlap diagram showing shared symptoms like fatigue irritability and low motivation

What the Research Actually Shows

The evidence on testosterone and depression isn’t as simple as “low T causes depression” or “TRT fixes it.” The research is nuanced, sometimes contradictory, and the details matter for treatment decisions.

Evidence that TRT can help depressive symptoms:

A 2019 meta-analysis published in JAMA Psychiatry analyzed 27 randomized controlled trials involving 1,890 men. The authors found that testosterone treatment was associated with a significant reduction in depressive symptoms compared to placebo, with an odds ratio of 2.30 for treatment efficacy. The effect was strongest when higher dosages were used in carefully selected populations (3).

A separate placebo-controlled trial focused specifically on older hypogonadal men with subthreshold depression (dysthymia or minor depression). After 12 weeks of testosterone gel, treated men showed greater reductions in Hamilton Depression Rating Scale scores and a higher remission rate of 52.9% compared to 18.8% in the placebo group (4).

The pattern across studies is relatively consistent: men with confirmed low testosterone and mild to moderate depressive symptoms tend to respond well to testosterone replacement. The response is strongest in dysthymia and persistent depressive disorder, and in men whose depression hasn’t responded to standard antidepressant treatment alone.

Evidence that demands caution:

A 2022 retrospective cohort study analyzing 70.3 million electronic health records found that testosterone use was independently associated with new-onset major depressive disorder (OR 1.99) and suicide attempt/intentional self-harm (OR 1.52). These associations remained significant even in the subgroup of men with confirmed testosterone deficiency (5).

This doesn’t mean TRT causes depression. The study couldn’t account for testosterone therapy adherence, whether men were receiving appropriate monitoring, or whether the testosterone was being managed in a clinically comprehensive way. But it does highlight a critical point: testosterone is not a benign supplement. It’s a hormone with profound neuropsychiatric effects, and it warrants the same level of clinical oversight as any other medication that affects the brain.

A systematic review from European Urology Focus examined placebo-controlled trials specifically in men with late-onset testosterone deficiency. The authors found that TRT reduced depressive symptoms in men with pretreatment mild depression, but this improvement was not seen in men with major depressive disorder (6). In other words, testosterone replacement helps with testosterone-driven mood symptoms, but it’s not a substitute for treating clinical depression.


How Testosterone Affects the Brain

Understanding the neuroscience helps explain why this overlap exists and why treatment needs to be precise.

Testosterone influences mood through several distinct pathways:

Serotonin modulation. Testosterone increases serotonin transporter expression and enhances the firing rate of serotonin-producing neurons in the dorsal raphe nucleus. Adequate serotonin activity is essential for mood stability, and testosterone deficiency can reduce serotonergic tone in ways that look clinically identical to depression (7).

Dopamine regulation. Testosterone promotes dopamine release in brain regions associated with motivation and reward. When testosterone drops, dopamine signaling decreases. This can manifest as anhedonia (loss of pleasure), reduced drive, and the flat affect that clinicians associate with depression.

GABA-A receptor activity. Testosterone and its metabolites act as modulators of GABA-A receptors, the brain’s primary inhibitory system. This affects anxiety regulation, stress response, and emotional reactivity. Low testosterone can increase baseline anxiety and reduce stress resilience (8).

When anxiety and low mood travel together in men, testosterone is one of the medical contributors worth checking. I go deeper in an online psychiatrist for anxiety in North Carolina.

Hippocampal neuroplasticity. Androgen deprivation reduces synaptic density in the hippocampus, a brain region critical for mood regulation and memory. Testosterone replacement has been shown to restore hippocampal cell proliferation in animal models (7). This may explain the cognitive symptoms (“brain fog,” poor concentration, memory complaints) that accompany both low testosterone and depression.

HPA axis interaction. The hypothalamic-pituitary-adrenal (HPA) axis (stress response) and the HPG axis (testosterone production) are inversely related. Chronic stress drives cortisol up and testosterone down. Depression amplifies this pattern, creating a feedback loop where mood problems and hormonal deficiency reinforce each other.

Low testosterone and depression brain pathways showing serotonin dopamine GABA and HPA axis interactions

Where the Diagnostic Gap Lives

The challenge isn’t that any single provider is doing something wrong. It’s that the evaluation for depression and the evaluation for low testosterone rarely happen together.

When depressive symptoms are the presenting complaint, hormonal labs often aren’t part of the initial workup. The symptoms fit a psychiatric diagnosis, treatment starts there, and the hormonal question never gets asked. If the depression is actually driven by low testosterone, antidepressant therapy alone won’t address the root cause.

When low testosterone is the presenting complaint, the evaluation typically focuses on hormonal labs and replacement. Mood symptoms may improve initially as energy and libido return. But if a standalone depressive disorder is also present, it can persist or resurface after the initial hormonal improvement plateaus.

In both cases, the gap is the same: one system gets evaluated while the other doesn’t. The patients who fall into this gap are the ones who feel partially better but never fully well. Men labeled as having treatment-resistant depression may have undiagnosed testosterone deficiency contributing to their symptoms.



The SSRI-Testosterone Interaction

There’s an additional complication that rarely gets discussed: the interaction between antidepressant medications and the hormonal system.

SSRIs are well known to cause sexual side effects, including decreased libido, erectile dysfunction, and delayed orgasm. These side effects overlap directly with the symptoms of low testosterone. A man with genuinely low T who’s placed on an SSRI may experience a compounding of sexual dysfunction that makes it impossible to distinguish medication effects from hormonal deficiency without lab work.

Research has also shown that men already on SSRIs who add testosterone replacement can experience significant improvement in depressive symptoms beyond what the SSRI alone achieved (10). This finding supports the idea that hormone and neurotransmitter systems need to be evaluated and treated together, not in isolation.

The clinical takeaway is that any man being treated for depression who reports persistent sexual dysfunction, fatigue, or treatment resistance should have a comprehensive hormonal panel checked. This isn’t optional; it’s part of a thorough psychiatric workup.


Who Should Be Evaluated for Low Testosterone

Not every depressed man has low testosterone, and not every man with low T is clinically depressed. But several clinical profiles warrant hormonal evaluation as part of a thorough psychiatric workup:

Men over 40 with new-onset depressive symptoms. Testosterone production begins declining around age 30 at approximately 1-2% per year. By 50, a meaningful percentage of men have levels below the clinical threshold. When depression first appears in this age range, testosterone should be on the differential.

Men with treatment-resistant depression. If a patient hasn’t responded to two or more adequate antidepressant trials, the diagnosis itself needs to be reconsidered. Unrecognized low testosterone is one of the most common correctable factors in treatment resistance.

Men with prominent physical symptoms. Depression doesn’t typically cause decreased muscle mass, increased body fat redistribution, or breast tissue changes. If these are present alongside mood symptoms, a hormonal cause should be investigated.

Men with sexual dysfunction as a leading complaint. While depression can reduce libido, the combination of erectile dysfunction, reduced morning erections, and decreased sexual desire is more characteristic of low testosterone than of a primary mood disorder.

Men with “irritable male syndrome.” A pattern of irritability, lethargy, anxiety, and social withdrawal, particularly when it doesn’t fit the classic presentation of major depressive disorder, may reflect testosterone-driven mood changes rather than a primary psychiatric condition (8).

Federal regulatory direction on this question is now shifting: in April 2026 the FDA invited testosterone drug sponsors to seek a new indication for testosterone therapy in men with idiopathic hypogonadism and low libido, which over the next few years may change what insurers cover and what physicians comfortably prescribe.


What Proper Evaluation Looks Like

A complete workup for a man presenting with depressive symptoms and suspected hormonal involvement includes both psychiatric and endocrine assessment.

Psychiatric evaluation: A structured clinical interview to assess for major depressive disorder, persistent depressive disorder (dysthymia), anxiety disorders, ADHD, and substance use. Validated rating scales (PHQ-9, GAD-7, or others) provide baseline measurements for tracking treatment response.

Hormonal labs: Morning total testosterone and free testosterone (testosterone levels peak in the morning and decline through the day, so timing matters). If initial results are low, repeat testing on a separate day is standard before diagnosing hypogonadism. Additional labs may include sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, and a metabolic panel.

Clinical context: The numbers alone don’t make the diagnosis. A total testosterone of 280 ng/dL in a man with classic hypogonadal symptoms has different clinical significance than the same level in an asymptomatic man. The American Urological Association uses 300 ng/dL as a general threshold for consideration of treatment, but symptoms, age, and the clinical picture all factor into the decision.

The critical point is that both evaluations need to happen together. Checking testosterone without a psychiatric assessment, or treating depression without checking hormones, means some patients will receive incomplete care.



The Integrated Approach

When both low testosterone and depression are present, treatment often involves addressing both conditions concurrently rather than waiting to see if fixing one resolves the other.

For men with confirmed hypogonadism and mild depressive symptoms, testosterone replacement alone may be sufficient. The Shores et al. trial showed over 50% remission of subthreshold depression with testosterone gel in 12 weeks, without any antidepressant (4).

For men with moderate to severe depression and low testosterone, a combined approach is more appropriate. An antidepressant addresses the neurochemical imbalance while TRT corrects the hormonal deficit. Research supports this combination: men on SSRIs who added TRT showed additional improvement in depressive symptoms beyond what the SSRI achieved alone (10).

The decision-logic for adding testosterone to an existing antidepressant, including who’s a candidate and who isn’t, is covered in more depth in the practice’s piece on testosterone augmentation for depression.

For men with depression and normal testosterone levels, TRT is not appropriate. The evidence does not support testosterone as a treatment for depression in eugonadal men. Supraphysiologic testosterone levels carry their own psychiatric risks, including mood instability, aggression, and the association with new-onset psychiatric symptoms seen in the 2022 cohort data (5).

Monitoring matters regardless of approach. Testosterone levels, mood symptoms, metabolic markers, and hematocrit should all be tracked at regular intervals. Treatment isn’t “set it and forget it”; it’s ongoing management that adjusts as the clinical picture changes.

For patients who had low testosterone and depression, whose depressive symptoms persist despite hormone optimization, emerging alternatives for treatment-resistant symptoms including investigational psychedelic therapies are receiving accelerated federal review.

Low testosterone and depression evaluation gap showing how integrated psychiatric and hormonal assessment closes the diagnostic blind spot

Frequently Asked Questions

Can low testosterone cause depression?

Low testosterone can produce symptoms that are clinically indistinguishable from depression, including fatigue, low motivation, irritability, poor concentration, and decreased interest in activities. Research consistently shows that men with hypogonadism have higher rates of depressive symptoms than men with normal testosterone levels. Whether low T directly “causes” depression in the psychiatric sense is still debated, but the symptom overlap is significant enough that hormonal evaluation should be part of any thorough depression workup in men.

Will TRT cure my depression?

It depends on what’s driving the depressive symptoms. If the primary issue is testosterone deficiency and the mood symptoms are secondary to that hormonal problem, TRT can produce significant improvement. Some studies show over 50% remission rates in men with subthreshold depression and confirmed low T. However, if the depression is a standalone psychiatric condition (major depressive disorder), TRT alone is unlikely to resolve it. The 2019 JAMA Psychiatry meta-analysis found that TRT was most effective for depressive symptoms in carefully selected populations with confirmed hypogonadism (3).

Should I get my testosterone checked if I’m already on an antidepressant?

Yes, particularly if the antidepressant isn’t fully resolving the symptoms, or if sexual dysfunction, fatigue, and low energy are prominent complaints. SSRIs can worsen sexual function, which makes it even harder to distinguish medication side effects from underlying low T. A morning testosterone panel is a simple blood test that can identify whether a hormonal component is being missed.

How do I know if my symptoms are from low testosterone or depression?

In many cases, the symptom presentation alone won’t answer this question definitively. Both conditions cause fatigue, mood changes, poor concentration, and decreased motivation. Physical symptoms like decreased muscle mass, increased body fat, breast tissue changes, reduced morning erections, and hot flashes are more specific to low testosterone and less typical of primary depression. The most reliable way to distinguish the two is a combination of psychiatric evaluation and morning testosterone lab work.

Can testosterone make depression worse?

It can. Supraphysiologic testosterone levels (levels pushed above the normal range) are associated with mood instability, irritability, aggression, and sleep disruption. A large 2022 cohort study found associations between testosterone therapy and new-onset depression and suicidality, though the study couldn’t determine causation or account for monitoring quality (5). This is one reason testosterone should be managed by a clinician who can monitor both hormonal levels and psychiatric symptoms.

Does insurance cover testosterone testing?

Most insurance plans cover testosterone lab work when ordered for a medical indication such as symptoms of hypogonadism or treatment-resistant depression. Cash-pay lab panels are also available through direct-to-consumer lab companies at reasonable cost. The initial evaluation typically includes total testosterone, free testosterone, and related markers.



How Dr. Baghel Approaches This

Dr. Baghel is a board-certified psychiatrist (ABPN) who also prescribes and manages testosterone replacement therapy. This means both the psychiatric evaluation and the hormonal assessment happen in the same appointment, with the same clinician, under one treatment plan.

For men presenting with depressive symptoms, Dr. Baghel’s evaluation includes a comprehensive psychiatric assessment alongside hormonal lab work. If both low testosterone and a mood disorder are identified, treatment is coordinated from the start rather than split across multiple providers.

Dr. Baghel conducts appointments all across North Carolina from his Wilmington office. No insurance is billed, which means no prior authorizations, no claim denials, and no limitations on which labs or treatments can be discussed.

Pricing is $250/month, flat rate, covering psychiatry and TRT under one plan. Month to month, with no contract and no minimum term. Labs and medications are paid separately by the patient.


This article is for educational purposes only and does not constitute medical advice. Depression and low testosterone are serious medical conditions that require professional evaluation. Do not start or stop any medication without consulting a qualified healthcare provider. Monthly plan covers Dr. Baghel’s clinical services only (evaluation, monitoring, medication management, ongoing care). Labs and medications are not included and are paid separately by the patient.


References

1. Anderson DJ, Vazirnia P, Loehr C, et al. Testosterone Replacement Therapy in the Treatment of Depression. Health Psychology Research. 2022;10(4):38956. doi:10.52965/001c.38956

2. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. Journal of Psychiatric Practice. 2009;15(4):289-305. doi:10.1097/01.pra.0000358315.88931.fc

3. Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019;76(1):31-40. doi:10.1001/jamapsychiatry.2018.2734

4. Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A Randomized, Double-Blind, Placebo-Controlled Study of Testosterone Treatment in Hypogonadal Older Men With Subthreshold Depression (Dysthymia or Minor Depression). Journal of Clinical Psychiatry. 2009;70(7):1009-1016. doi:10.4088/jcp.08m04478

5. Nackeeran S, Patel MS, Nallakumar DT, et al. Testosterone Therapy is Associated With Depression, Suicidality, and Intentional Self-Harm: Analysis of a National Federated Database. Journal of Sexual Medicine. 2022;19(6):933-939. doi:10.1016/j.jsxm.2022.03.611

6. Vartolomei MD, Kimura S, Vartolomei L, Shariat SF. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency. European Urology Focus. 2020;6(1):170-177. doi:10.1016/j.euf.2018.07.006

7. Carrier N, Saland SK, Duclot F, et al. The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in Gonadectomized Male Rats. Biological Psychiatry. 2015;78(4):259-269. doi:10.1016/j.biopsych.2014.12.024

8. Zitzmann M. Testosterone, mood, behaviour and quality of life. Andrology. 2020;8(6):1598-1605. doi:10.1111/andr.12867

9. Layton JB, Li D, Meier CR, et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. Journal of Clinical Endocrinology and Metabolism. 2014;99(3):835-842. doi:10.1210/jc.2013-3570

10. Khera M. Patients with testosterone deficit syndrome and depression. Current Opinion in Urology. 2013;66(7):729-736.


Related Articles

TRT Side Effects: What to Watch For

Gynecomastia on TRT: Causes, Prevention, and Treatment

Cash-Pay Psychiatrist in North Carolina: What to Know Before You Book

GLP-1 Medications and Mental Health: What Your Psychiatrist Wants You to Know

ADHD: Pathophysiology, Treatment Mechanisms, and Emerging Research

Begin care

Schedule a free consultation

Shantanu Baghel

Board-certified · Psychiatry & forensic psychiatry

Dr. Baghel runs Baghel Psychiatry, a cash-pay telehealth practice serving adults across North Carolina, with a particular focus on the overlap between mood, hormones, and metabolism, and on supervised antidepressant discontinuation.

More writing

Begin

Get a Comprehensive Evaluation in North Carolina